Lessons from constitutively active mutants of G protein-coupled receptors

Trends in Endocrinology and Metabolism

Volumn 13, Issue 8, 2002, Pages 336-343

  Parnot, Charles ^a   Miserey Lenkei, Stéphanie ^a   Bardin, Sabine ^a   Corvol, Pierre ^b   Clauser, Eric ^a  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; ARPA PROTEIN, STREPTOMYCES GRISEUS; BACTERIAL PROTEIN; BETA 2 ADRENERGIC RECEPTOR; CELL SURFACE RECEPTOR; DNA BINDING PROTEIN; REPRESSOR PROTEIN; THYROTROPIN RECEPTOR;

CANCER; CONFORMATION; ENDOCRINE SYSTEM; INTERNALIZATION; MUTANT; PATHOPHYSIOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; HUMAN; MOLECULAR GENETICS; MUTATION; PHYSIOLOGY; PROTEIN CONFORMATION; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; DNA-BINDING PROTEINS; GTP-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ANGIOTENSIN; RECEPTORS, CELL SURFACE; RECEPTORS, THYROTROPIN; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 0036783213     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(02)00628-8     Document Type: Review

References (70)

1. Gether, U. (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21, 90-113
2. Kenakin, T. (2001) Inverse, protean, and ligandselective agonism: matters of receptor conformation. FASEB J. 15, 598-611
3. Kenakin, T. (2002) Drug efficacy at G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 42, 349-379
4. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. U. S. A. 87,2896-2900
5. Horn, F. et al. (2001) Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems. Nucleic Acids Res, 29, 346-349
6. Costa, T. and Herz, A. (1989) Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 86, 7321-7325
7. 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J. Biol. Chem. 267, 1430-1433
8. Cohen, G.B. et al. (1993) Constitutive activation of opsin: influence of charge at position 134 and size at position 296. Biochemistry 32, 6111-6115
9. Arnis, S. et al. (1994)A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J. Biol. Chem. 269, 23879-23881
10. 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J. 15, 3566-3578
11. 1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc. Natl. Acad. Sci. U. S. A. 94, 808-813
12. 2-adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol. Pharmacol. 56, 175-184
13. 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276, 29171-29177
14. Ballesteros, J. et al. (1998) Functional microdomains in G protein-coupled receptors. The conserved arginine-cage motif in the gonadotropin-releasing hormone receptor. J. Biol. Chem. 273, 10445-10453
15. Lu, Z.L. et al. (1997) The role of the aspartate-arginine-tyrosine triad in the ml muscarinic receptor: mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling. Mol. Pharmacol. 51, 234-241
16. Palczewski, K. et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-745
17. Han, M. et al. (1998) Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6. Biochemistry 37, 8253-8261
18. 111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation. J. Biol. Chem. 272, 1822-1826
19. Balmforth, A.J. et al. (1997) The conformational change responsible for AT1 receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII. J. Biol. Chem. 272, 4245-4251
20. Pauwels, P.J. and Wurch, T. (1998) Review: amino acid domains involved in constitutive activation of G protein-coupled receptors. Mol. Neurobiol. 17, 109-135
21. Nishi, S. et al. (2002) The ectodomain of the luteinizing hormone receptor interacts with exoloop 2 to constrain the transmembrane region: studies using chimeric human and fly receptors. J. Biol. Chem. 277, 3958-3964
22. Prezeau, L. et al. (1996) Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity. Mol. Pharmacol. 49, 422-429
23. Spalding, T.A. et al. (1998) Identification of a ligand-dependent switch within a muscarinic receptor. J. Biol. Chem. 273, 21563-21568
24. Burstein, E.S. et al. (1998) The second intracellular loop of the m5 muscarinic receptor is the switch which enables G protein coupling. J. Biol. Chem. 273, 24322-24327
25. Spalding, T.A. and Burstein, E.S. (2001) Constitutively active muscarinic receptors. Life Sci. 68, 2511-2516
26. Parnot, C. et al. (2000) Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay. Proc. Natl. Acad. Sci. U. S. A. 97, 7615-7620
27. 1B-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J. Biol. Chem. 276, 46485-46494
28. Geva, A. et al. (2000) Genetic mapping of the human C5A receptor. Identification of transmembrane amino acids critical for receptor function. J. Biol. Chem. 275, 35393-35401
29. Dube, P. and Konopka, J.B. (1998) Identification of a polar region in transmembrane domain 6 that regulates the function of the G protein-coupled α-factor receptor. Mol. Cell. Biol. 18, 7205-7215
30. Parrish, W. et al. (2002) The cytoplasmic end of transmembrane domain 3 regulates the activity of the Saccharomyces cerevisiae G protein-coupled α-factor receptor. Genetics 160, 429-443
31. Gether, U. et al. (1997) Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J. Biol. Chem. 272, 2587-2590
32. 1B-adrenergic receptor mutants display different phosphorylation and internalization features. Mol. Pharmacol. 55, 339-347
33. Thomas, W.G. et al. (2000)Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphatesignaling state. J. Biol. Chem. 275, 2893-2900
34. Schipani, E. et al. (1997) Constitutive activation of the cyclic adenosine 3′,5′-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia. Mol. Endocrinol. 11, 851-858
35. Rolz, C. et al. (1999) Molecular characterization of the receptor-ligand complex for parathyroid hormone. Biochemistry 38, 6397-6405
36. Carter, P.H. et al. (2001) Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations. Endocrinology 142, 1534-1545
37. Ferguson, S.S. (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53, 1-24
38. Min, K.S. et al. (1998) Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the lutropin/choriogonadotropin receptor. J. Biol. Chem. 273, 34911-34919
39. Min, L. and Ascoli, M. (2000) Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor. Mol. Endocrinol. 14, 1797-1810
40. 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc. Natl. Acad. Sci. U. S. A. 91, 2699-2702
41. Miserey-Lenkei, S. et al. (2002) Constitutive internalization of constitutively active angiotensin II AT(1A) receptor mutants is blocked by inverse agonists. J. Biol. Chem. 277, 5891-5901
42. Shapiro, M.J. et al. (1996) Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization. J. Biol. Chem. 271, 32874-32880
43. Tarasova, N.I. et al. (1997) Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J. Biol. Chem. 272, 14817-14824
44. Heinflink, M. et al. (1995) A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist. Mol. Endocrinol. 9, 1455-1460
45. 1B-adrenoceptor by ligands that act as inverse agonists. Biochem. J. 325, 733-739
46. 1B-adrenoceptor. Mol. Pharmacol. 58, 438-448
47. Smit, M.J. et al. (1996) Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. Proc. Natl. Acad. Sci. U. S. A. 93, 6802-6807
48. Stefan, C.J. et al. (1998) Mechanisms governing the activation and trafficking of yeast G protein-coupled receptors. Mol. Biol. Cell 9, 885-899
49. Parma, J. et al. (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365, 649-651
50. Shenker, A. et al. (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365, 652-654
51. Gromoll, J. et al. (1996) An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J. Clin. Endocrinol. Metab. 81, 1367-1370
52. Rao, VR. et al. (1994) Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367, 639-642
53. Schipani, E. et al. (1995)A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268, 98-100
54. Chattopadhyay, N. et al. (1996) The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocr Rev. 17, 289-307
55. Kijas, J.M. et al. (1998) Melanocortin receptor 1 (MC1R) mutations and coat color in pigs. Genetics 150, 1177-1185
56. Morello, J.P. et al. (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest. 105, 887-895
57. Davies, E. et al. (1997) Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 82, 611-615
58. Schipani, E. et al. (1997) Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc. Natl. Acad. Sci. U. S. A. 94, 13689-13694
59. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 91, 10109-10113
60. 2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 94, 137-141
61. 1A-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ. Res. 89, 343-350
62. 1B-adrenergic receptor induces dilated cardiomyopathy. Am. J. Physiol. 281, H931-938
63. 1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 96, 7059-7064
64. 2-adrenoceptor. Nature 374, 272-276
65. Hein, L. et al. (1997) Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc. Natl. Acad. Sci. U. S. A. 94, 6391-6396
66. Young, D. et al. (1986) Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 45, 711-719
67. 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc. Natl. Acad. Sci. U. S. A. 88, 11354-11358
68. Bais, C. et al. (1998) G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391, 86-89
69. Xie, J. et al. (1998) Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391, 90-92
70. Cohen, D.P. et al. (1997) Human calcitonin receptors exhibit agonist-independent (constitutive) signaling activity. Endocrinology 138, 1400-1405